DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens  of various pathogens as genetically engineered vaccines  both  preventive and ther...

Celý popis

Podrobná bibliografie

Hlavní autoři:	L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov
Médium:	Artigo
Jazyk:	Russo
Vydáno:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2017-08-01
Edice:	Медицинская иммунология
Témata:	adenoviral vector vaccine clinical trials infectious diseases human adenovirus chimpanzee adenovirus
On-line přístup:	https://www.mimmun.ru/mimmun/article/view/1307
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!